Skip to content

A case-control study on the expression of zinc alpha2 glycoprotein in nonalcoholic fatty liver disease and thyroid disease

A case-control study on the expression of zinc alpha2 glycoprotein in nonalcoholic fatty liver disease and thyroid disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012943
Enrollment
Unknown
Registered
2017-10-11
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease

Interventions

Case series:N/A

Sponsors

the First Affiliated Hospital of University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: NAFLD 1. Aged 18 to 70 years; 2. clinically defined as manifestations of B ultrasonography, and No excessive alcohol intake ( female < 20g/d, male < 30g/d); 3. volunteered to participate in the study and signed informed consent; Hyperthyroidism: 1. Aged 18 to 70 years; 2. dignosed with hyperthyroidism by tipical presentation, elevated serum TH, reduced thyroid-stimulating hormone (TSH), but TSH receptor antibody (TRAb) levels in these patients may increased or normal; 3. diagnosed with hyperthyroidism for the first time. 4. volunteered to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: NAFLD 1. Consciousness disorder or unable to move freely; 2. Severe heart, brain, liver, kidney and other organic lesions or patients with malignant tumors. 3. Hepatitis B and hepatitis; 4. Pregnant or lactating women. Hyperthyroidism: BMI > 35 kg/m2, known cardiovascular disease, neoplasms, smoking, diabetes, hypertension, and renal impairment (serum creatinine 120 µmol/L).

Design outcomes

Primary

MeasureTime frame
Zinc-a2-glycoprotein;

Countries

China

Contacts

Public ContactXiao Xin-hua

the First Affiliated Hospital of University of South China

xiaoxinhua139@163.com+86 13974703153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026